Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy
Clinical trial NCT06942377 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06942377
- Sponsor
- Peking University People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2027-01-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.